Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

K J Osterziel; O Strohm; Jochen Schuler; M Friedrich; D Hänlein; R Willenbrock; S D Anker; P A Poole-Wilson; M B Ranke; R Dietz

doi:10.1016/S0140-6736(97)11329-0

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

K J Osterziel, O Strohm, Jochen Schuler (Co-author), M Friedrich, D Hänlein, R Willenbrock, S D Anker, P A Poole-Wilson, M B Ranke, R Dietz

Research output: Contribution to journal › Original Article › peer-review

285 Citations (Web of Science)

Original language	English
Pages (from-to)	1233-1237
Journal	LANCET
Volume	351
Issue number	9111
DOIs	https://doi.org/10.1016/S0140-6736(97)11329-0
Publication status	Published - 1998

Keywords

BODY-MASS INDEX
FACTOR-I
SERUM LEVELS
DEFICIENT ADULTS
IGF-I
AGE
VARIABILITY
REPERFUSION
PERFORMANCE
SECRETION

Access to Document

10.1016/S0140-6736(97)11329-0

Cite this

Osterziel, K. J., Strohm, O., Schuler, J., Friedrich, M., Hänlein, D., Willenbrock, R., Anker, S. D., Poole-Wilson, P. A., Ranke, M. B., & Dietz, R. (1998). Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. LANCET , 351(9111), 1233-1237. https://doi.org/10.1016/S0140-6736(97)11329-0

Osterziel, K J ; Strohm, O ; Schuler, Jochen et al. / Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. In: LANCET 1998 ; Vol. 351, No. 9111. pp. 1233-1237.

@article{2ec3bf8375dc4830ab2c32eac6079608,

title = "Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.",

keywords = "BODY-MASS INDEX, FACTOR-I, SERUM LEVELS, DEFICIENT ADULTS, IGF-I, AGE, VARIABILITY, REPERFUSION, PERFORMANCE, SECRETION",

author = "Osterziel, {K J} and O Strohm and Jochen Schuler and M Friedrich and D H{\"a}nlein and R Willenbrock and Anker, {S D} and Poole-Wilson, {P A} and Ranke, {M B} and R Dietz",

year = "1998",

doi = "10.1016/S0140-6736(97)11329-0",

language = "English",

volume = "351",

pages = "1233--1237",

journal = "LANCET ",

issn = "0140-6736",

publisher = "Elsevier ",

number = "9111",

}

Osterziel, KJ, Strohm, O, Schuler, J, Friedrich, M, Hänlein, D, Willenbrock, R, Anker, SD, Poole-Wilson, PA, Ranke, MB & Dietz, R 1998, 'Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.', LANCET , vol. 351, no. 9111, pp. 1233-1237. https://doi.org/10.1016/S0140-6736(97)11329-0

Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. / Osterziel, K J; Strohm, O; Schuler, Jochen (Co-author) et al.
In: LANCET , Vol. 351, No. 9111, 1998, p. 1233-1237.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy.

AU - Osterziel, K J

AU - Strohm, O

AU - Schuler, Jochen

AU - Friedrich, M

AU - Hänlein, D

AU - Willenbrock, R

AU - Anker, S D

AU - Poole-Wilson, P A

AU - Ranke, M B

AU - Dietz, R

PY - 1998

Y1 - 1998

KW - BODY-MASS INDEX

KW - FACTOR-I

KW - SERUM LEVELS

KW - DEFICIENT ADULTS

KW - IGF-I

KW - AGE

KW - VARIABILITY

KW - REPERFUSION

KW - PERFORMANCE

KW - SECRETION

U2 - 10.1016/S0140-6736(97)11329-0

DO - 10.1016/S0140-6736(97)11329-0

M3 - Original Article

C2 - 9643742

SN - 0140-6736

VL - 351

SP - 1233

EP - 1237

JO - LANCET

JF - LANCET

IS - 9111

ER -

Osterziel KJ, Strohm O, Schuler J, Friedrich M, Hänlein D, Willenbrock R et al. Randomised, double-blind, placebo-controlled trial of human recombinant growth hormone in patients with chronic heart failure due to dilated cardiomyopathy. LANCET . 1998;351(9111):1233-1237. doi: 10.1016/S0140-6736(97)11329-0